The Expansion of Pharmacy-Based Test and Treat Programs for Infectious Diseases: Impact, Challenges, and Future Directions

Pharmacy-based test and treatment programs are increasingly transforming healthcare by offering accessible, convenient, and effective care for common infectious diseases. These programs enable pharmacists to provide same-day testing and treatment, particularly for illnesses like influenza, strep throat, and COVID-19. Doing so addresses critical healthcare gaps, especially in underserved or rural areas with limited primary care resources. This article explores the impact of pharmacy-based test and treatment programs on public health and healthcare access, highlighting improvements in patient outcomes, increased healthcare convenience, and reduced burden on primary care providers. However, the need for additional pharmacist training, inconsistent reimbursement policies, and regulatory variability across states could rove these programs' expansion. Despite these challenges, advancements in diagnostic technology and the potential for telemedicine integration suggest promising avenues for sustainable growth. Legislative and policy support, such as standardizing pharmacists' scope of practice and ensuring fair reimbursement, is essential to realize these programs' benefits fully. As pharmacy-based test and treatment services continue to evolve, they offer a valuable public health resource that has the potential to reshape healthcare delivery, enhance health equity, and strengthen the healthcare system overall.